Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments.

Eriksson JE, He T, Trejo-Skalli AV, Härmälä-Braskén AS, Hellman J, Chou YH, Goldman RD.

J Cell Sci. 2004 Feb 29;117(Pt 6):919-32. Epub 2004 Feb 3.

2.

Type-2A protein phosphatase activity is required to maintain death receptor responsiveness.

Härmälä-Braskén AS, Mikhailov A, Söderström TS, Meinander A, Holmström TH, Damuni Z, Eriksson JE.

Oncogene. 2003 Oct 23;22(48):7677-86.

PMID:
14576831
3.

Identification of ATP-synthase as a novel intracellular target for microcystin-LR.

Mikhailov A, Härmälä-Braskén AS, Hellman J, Meriluoto J, Eriksson JE.

Chem Biol Interact. 2003 Jan 6;142(3):223-37.

PMID:
12453662
4.

Production and specificity of monoclonal antibodies against nodularin conjugated through N-methyldehydrobutyrine.

Mikhailov A, Härmälä-Braskén AS, Polosukhina E, Hanski A, Wahlsten M, Sivonen K, Eriksson JE.

Toxicon. 2001 Oct;39(10):1453-9.

PMID:
11478952
5.

Production and specificity of mono and polyclonal antibodies against microcystins conjugated through N-methyldehydroalanine.

Mikhailov A, Härmälä-Braskén AS, Meriluoto J, Sorokina Y, Dietrich D, Eriksson JE.

Toxicon. 2001 Apr;39(4):477-83.

PMID:
11024487
7.

Strategies to assess phosphoprotein phosphatase and protein kinase-mediated regulation of the cytoskeleton.

Eriksson JE, Toivola DM, Sahlgren C, Mikhailov A, Härmälä-Braskén AS.

Methods Enzymol. 1998;298:542-69. No abstract available.

PMID:
9751907

Supplemental Content

Loading ...
Support Center